Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "NEJM" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about NEJM for you to read. Along with our medical data and news we also list NEJM Clinical Trials, which are updated daily. BioPortfolio also has a large database of NEJM Companies for you to search.
Might this new approach actually become a standard therapy?
Two studies raise concerns about laparoscopic and robotic hysterectomy for early-stage disease.
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancer, Published online: 14 November 2018; doi:10.1038/s41523-018-0090-6A commonly used genetic test helps to predict whether patients with estrogen-receptor positive, node-negative breast cancer stand to gain from chemotherapy. Charles Geyer ...
In cases of acute flaccid myelitis (AFM), most patients experience fever or respiratory symptoms 3 to 10 days before developing limb weakness — leading researchers to...
See what's happening around NEJM Group: NEJM Resident 360: Clinical pearls: How long after initial infection do patients with Lyme meningoradiculitis typically present? What cranial...
A decision support system integrated into the electronic medical record (EMR) can help to safely discharge low-risk patients with pulmonary embolism (PE) from the...
Dr. Paul Sax shares his frustrations on sharing radiology images via CD-ROM and offers a five-step solution to move image sharing into the...
Long-term efficacy data show that TDF monotherapy is equally as safe and effective as combination therapy.
The GRAIL model is superior to other well-known GFR estimating equations.
Supplements did not lower the overall incidence of adverse cardiovascular events in a large randomized trial.
Vitamin D did not prevent adverse cardiovascular events or cancer in a large randomized trial.
A meta-analysis suggests more toxicity but better efficacy from the recombinant vaccine.